Answers are grounded in this paper and cite their sources.
Achieving high-contrast, deep-tissue imaging remains a formidable challenge in non-invasive diagnostics due to ubiquitous autofluorescence interference. While hot-band absorption (HBA)-mediated frequency upconversion luminescence (HBA/FUCL) offers a powerful solution, the repertoire of active molecular structures remains severely limited. Here, we introduce nanoDPP-CN, a novel HBA/FUCL nanoprobe that harnesses a diketopyrrolopyrrole (DPP) core for the ultra-selective detection of hydrogen sulfide (H₂S). By functionalizing the DPP core with a cyano-vinylene framework, the DPP-CN probe triggers a distinct fluorescence shift upon H₂S interaction. Crucially, encapsulating this probe within a biocompatible castor oil/Pluronic F127 matrix not only guarantees stable aqueous dispersion but actively shields the core from competing biologically reactive species, unlocking unprecedented target selectivity. Operating via the single-photon HBA/FUCL process, nanoDPP-CN effectively suppresses tissue autofluorescence, yielding a significantly enhanced signal-to-background ratio. We successfully validated its translational potential by mapping endogenous H₂S in real-time within LPS-induced arthritic joints and accurately diagnosing plasma H₂S deficiencies in type-1 diabetic models. This straightforward yet robust nanoengineering strategy transforms a conventional dye into an advanced FUCL diagnostic tool, setting a new benchmark for the high-precision, non-invasive monitoring of H₂S-related diseases.
No takes yet. Share an insight, caveat, or question.
Seo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: